Published in Lab Law Weekly, August 19th, 2005
Present day estimates indicate that generic prescriptions have risen to or exceeded the number of branded prescriptions written. To support these estimates a new study produced by researchers at Cutting Edge Information shows that between 1984 and 2002, generics' prescription share has risen steadily from 19% to 47%.
"Branded drugs that produced more than 15 billion dollars in U.S. sales alone will or already have lost their marketing exclusivity by 2005," said Elio Evangelista, senior analyst at Cutting Edge Information. It is crucial, he...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.